X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16461) 16461
Publication (1711) 1711
Newspaper Article (460) 460
Newsletter (375) 375
Book Review (292) 292
Book Chapter (98) 98
Transcript (72) 72
Conference Proceeding (19) 19
Dissertation (19) 19
Magazine Article (19) 19
Trade Publication Article (13) 13
Government Document (8) 8
Data Set (5) 5
Streaming Video (5) 5
Book / eBook (4) 4
Web Resource (3) 3
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11023) 11023
index medicus (10632) 10632
angiogenesis (10564) 10564
oncology (6818) 6818
animals (6266) 6266
cancer (6160) 6160
female (4832) 4832
male (4161) 4161
vascular endothelial growth factor (3497) 3497
mice (3378) 3378
angiogenesis inhibitors - therapeutic use (3216) 3216
angiogenesis inhibitors (3169) 3169
chemotherapy (3138) 3138
endothelial growth-factor (3030) 3030
tumors (3024) 3024
metastasis (2993) 2993
bevacizumab (2980) 2980
care and treatment (2973) 2973
apoptosis (2849) 2849
research (2603) 2603
middle aged (2555) 2555
aged (2342) 2342
expression (2255) 2255
cancer therapies (2021) 2021
pharmacology & pharmacy (2010) 2010
cell line, tumor (1996) 1996
adult (1972) 1972
treatment outcome (1855) 1855
health aspects (1845) 1845
analysis (1833) 1833
proteins (1795) 1795
antineoplastic agents - therapeutic use (1778) 1778
angiogenesis inhibitors - pharmacology (1756) 1756
therapy (1728) 1728
kinases (1654) 1654
medicine & public health (1563) 1563
clinical trials (1442) 1442
vegf (1383) 1383
neovascularization, pathologic - drug therapy (1373) 1373
angiogenesis inhibitors - administration & dosage (1358) 1358
cell biology (1350) 1350
cell proliferation - drug effects (1315) 1315
neoplasms - drug therapy (1306) 1306
medicine (1299) 1299
drug therapy (1293) 1293
growth (1285) 1285
antineoplastic combined chemotherapy protocols - therapeutic use (1277) 1277
breast cancer (1273) 1273
inhibition (1269) 1269
antineoplastic agents - pharmacology (1257) 1257
gene expression (1250) 1250
angiogenesis inhibitors - adverse effects (1223) 1223
studies (1194) 1194
cells (1176) 1176
signal transduction (1146) 1146
research article (1145) 1145
toxicity (1138) 1138
article (1133) 1133
in-vitro (1107) 1107
biochemistry & molecular biology (1098) 1098
tumor angiogenesis (1078) 1078
antineoplastic agents (1064) 1064
neovascularization (1058) 1058
survival (1058) 1058
medicine, research & experimental (1052) 1052
apoptosis - drug effects (1049) 1049
development and progression (1039) 1039
rats (1038) 1038
hematology, oncology and palliative medicine (1035) 1035
medical research (1032) 1032
multidisciplinary sciences (1025) 1025
rodents (1013) 1013
in-vivo (1005) 1005
vascular endothelial growth factor a - antagonists & inhibitors (1003) 1003
antimitotic agents (981) 981
cell proliferation (980) 980
mice, nude (979) 979
dose-response relationship, drug (957) 957
hypoxia (943) 943
inflammation (922) 922
hematology (920) 920
cell growth (910) 910
vascular endothelial growth factor a - metabolism (909) 909
aged, 80 and over (897) 897
review (892) 892
colorectal cancer (891) 891
metastases (885) 885
xenograft model antitumor assays (883) 883
physiological aspects (875) 875
signal transduction - drug effects (874) 874
science (865) 865
biology (855) 855
tumor-growth (849) 849
endothelial cells (844) 844
activation (837) 837
antibodies, monoclonal, humanized (834) 834
disease models, animal (834) 834
cell cycle (828) 828
lung cancer (820) 820
disease-free survival (816) 816
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17337) 17337
French (90) 90
Japanese (39) 39
German (23) 23
Chinese (22) 22
Polish (8) 8
Russian (8) 8
Spanish (8) 8
Turkish (4) 4
Hungarian (3) 3
Korean (3) 3
Italian (2) 2
Portuguese (2) 2
Czech (1) 1
Dutch (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2016, Volume 78, Issue 1, pp. 63 - 71
Journal Article
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 12/2013, Volume 273, Issue 2, pp. 418 - 424
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 10/2019, Volume 25, Issue 7, pp. 1749 - 1753
Journal Article
Cardiovascular and Hematological Agents in Medicinal Chemistry, ISSN 1871-5257, 04/2017, Volume 15, Issue 1, pp. 3 - 16
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 2017, Volume 24, Issue 13, pp. 1365 - 1381
Gliomas are the most common primary malignant brain tumors, which have a universally fatal outcome. Current standard treatment for glioma patients is surgical... 
Clinical trials | Glioma stem cell | Glioma | Targeted therapy | Cell signal transduction pathway | Immunotherapy | targeted therapy | STEM-CELLS | CHEMISTRY, MEDICINAL | NEWLY-DIAGNOSED GLIOBLASTOMA | PROGRESSION-FREE SURVIVAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECURRENT GLIOBLASTOMA | cell signal transduction pathway | BRAIN-TUMORS | MALIGNANT GLIOMA | GROWTH-FACTOR RECEPTOR | PHASE-II TRIAL | glioma stem cell | IN-VIVO | PHARMACOLOGY & PHARMACY | clinical trials | HIGH-GRADE GLIOMA | Humans | Brain Neoplasms - pathology | Antibodies, Monoclonal - therapeutic use | Phosphatidylinositol 3-Kinases - metabolism | Stem Cells - cytology | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Stem Cells - metabolism | Brain Neoplasms - metabolism | Alkylating Agents - therapeutic use | Glioma - metabolism | Stem Cell Transplantation | Protein Kinase Inhibitors - chemistry | Alkylating Agents - toxicity | Glioma - pathology | Glioma - therapy | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Antibodies, Monoclonal - immunology | Receptor Protein-Tyrosine Kinases - metabolism | Alkylating Agents - chemistry | Angiogenesis Inhibitors - toxicity | Signal Transduction - drug effects | Protein Kinase Inhibitors - therapeutic use | Brain Neoplasms - therapy | Protein Kinase Inhibitors - toxicity | Angiogenesis Inhibitors - chemistry | Tyrosine | Brain | Epidermal growth factor receptors | Brain tumors | Brain cancer | MAP kinase | Raf protein | AKT protein | Radiation therapy | Patients | 1-Phosphatidylinositol 3-kinase | Receptors | Chemotherapy | Surgery | Stem cells | Protein-tyrosine kinase
Journal Article
Acta Oncologica, ISSN 0284-186X, 08/2013, Volume 52, Issue 6, pp. 1202 - 1212
Abstract Purpose. The angiogenesis inhibitor pazopanib has been approved for the treatment of advanced renal cell cancer (RCC) and soft tissue sarcoma. Severe... 
MONOTHERAPY | ONCOLOGY | RECURRENT | BEVACIZUMAB | PHASE-II | OPEN-LABEL | TUMOR-GROWTH | CARCINOMA | SOFT-TISSUE SARCOMA | ENDOTHELIAL GROWTH-FACTOR | Liver - drug effects | Humans | Risk Factors | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Neoplasms - drug therapy | Index Medicus
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 01/2013, Volume 441, Issue 1-2, pp. 285 - 290
Journal Article